Evercore ISI maintains Veeva Systems' In-Line rating, raises PT to $295.
PorAinvest
jueves, 28 de agosto de 2025, 9:04 am ET1 min de lectura
VEEV--
Veeva Systems reported total revenue of $789.1 million, representing a 17% year-over-year growth and exceeding expectations of approximately $768 million. Earnings per share came in at $1.99, ahead of the consensus estimate of $1.90. However, billings of $666 million fell slightly short of the $666.5 million consensus. The company maintains impressive profitability with a 75.5% gross margin and strong return metrics, earning it a "GREAT" financial health score from InvestingPro [1].
The company raised its full-year fiscal 2026 guidance across all metrics. Total revenue guidance was increased by $40 million to a range of $3.134-$3.140 billion. Operating income guidance was raised by $28 million to $1.388 billion, while normalized billings guidance increased by $35 million to $3.355 billion. This outlook builds on the company’s strong track record, with revenue growing at 14.78% over the last twelve months [1].
Crossix was identified as the key driver of commercial solutions growth, with revenue up 13% year-over-year to $307.5 million. The company’s partnership with IQVIA was highlighted as bringing multiple benefits that should unfold over time, particularly enhancing Veeva Nitro’s value in commercial analytics [1].
Veeva has secured verbal commitments from two additional top-20 biopharma companies, bringing the total to 9 of the top 20, while its CRM product secured another verbal commitment, bringing that total to 3. Vault migrations are reportedly progressing well, with two top-20 biopharmas now live [1].
In other recent news, Veeva Systems reported impressive financial results for the fiscal second quarter, exceeding market expectations. The company achieved revenue of $789.1 million, marking a 17% increase year-over-year and surpassing consensus estimates of $768 million. Adjusted operating income reached $352.6 million, a 26% rise from the previous year, also beating expectations. Analysts responded positively to these results, with BTIG, Raymond James, and Baird adjusting their price targets upwards [1].
References:
[1] https://www.investing.com/news/analyst-ratings/veeva-systems-stock-price-target-raised-to-295-by-evercore-isi-93CH-4214407
Evercore ISI maintains Veeva Systems' In-Line rating, raises PT to $295.
Evercore ISI has raised its price target on Veeva Systems (NYSE:VEEV) to $295.00 from $285.00, while maintaining an "In Line" rating following the company’s quarterly earnings report. The stock is currently trading near its 52-week high of $296.72, with InvestingPro data indicating the stock is slightly overvalued at current levels [1].Veeva Systems reported total revenue of $789.1 million, representing a 17% year-over-year growth and exceeding expectations of approximately $768 million. Earnings per share came in at $1.99, ahead of the consensus estimate of $1.90. However, billings of $666 million fell slightly short of the $666.5 million consensus. The company maintains impressive profitability with a 75.5% gross margin and strong return metrics, earning it a "GREAT" financial health score from InvestingPro [1].
The company raised its full-year fiscal 2026 guidance across all metrics. Total revenue guidance was increased by $40 million to a range of $3.134-$3.140 billion. Operating income guidance was raised by $28 million to $1.388 billion, while normalized billings guidance increased by $35 million to $3.355 billion. This outlook builds on the company’s strong track record, with revenue growing at 14.78% over the last twelve months [1].
Crossix was identified as the key driver of commercial solutions growth, with revenue up 13% year-over-year to $307.5 million. The company’s partnership with IQVIA was highlighted as bringing multiple benefits that should unfold over time, particularly enhancing Veeva Nitro’s value in commercial analytics [1].
Veeva has secured verbal commitments from two additional top-20 biopharma companies, bringing the total to 9 of the top 20, while its CRM product secured another verbal commitment, bringing that total to 3. Vault migrations are reportedly progressing well, with two top-20 biopharmas now live [1].
In other recent news, Veeva Systems reported impressive financial results for the fiscal second quarter, exceeding market expectations. The company achieved revenue of $789.1 million, marking a 17% increase year-over-year and surpassing consensus estimates of $768 million. Adjusted operating income reached $352.6 million, a 26% rise from the previous year, also beating expectations. Analysts responded positively to these results, with BTIG, Raymond James, and Baird adjusting their price targets upwards [1].
References:
[1] https://www.investing.com/news/analyst-ratings/veeva-systems-stock-price-target-raised-to-295-by-evercore-isi-93CH-4214407

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios